Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 1
1964 3
1966 1
1967 2
1969 1
1970 1
1971 4
1972 5
1973 4
1974 3
1975 1
1976 5
1977 3
1978 3
1979 4
1980 5
1981 10
1982 7
1983 5
1984 6
1985 13
1986 6
1987 9
1988 17
1989 12
1990 10
1991 12
1992 22
1993 21
1994 12
1995 23
1996 18
1997 14
1998 12
1999 15
2000 17
2001 9
2002 17
2003 21
2004 21
2005 31
2006 31
2007 28
2008 35
2009 31
2010 32
2011 35
2012 38
2013 43
2014 42
2015 50
2016 35
2017 42
2018 45
2019 38
2020 53
2021 48
2022 53
2023 40
2024 32

Text availability

Article attribute

Article type

Publication date

Search Results

1,060 results

Results by year

Filters applied: . Clear all
Page 1
DA-EPOCH-R combined with high-dose methotrexate in patients with newly diagnosed stage II-IV CD5-positive diffuse large B-cell lymphoma: a single-arm, open-label, phase II study.
Miyazaki K, Asano N, Yamada T, Miyawaki K, Sakai R, Igarashi T, Nishikori M, Ohata K, Sunami K, Yoshida I, Yamamoto G, Takahashi N, Okamoto M, Yano H, Nishimura Y, Tamaru S, Nishikawa M, Izutsu K, Kinoshita T, Suzumiya J, Ohshima K, Kato K, Katayama N, Yamaguchi M. Miyazaki K, et al. Among authors: sakai r. Haematologica. 2020 Sep 1;105(9):2308-2315. doi: 10.3324/haematol.2019.231076. Haematologica. 2020. PMID: 33054055 Free PMC article. Clinical Trial.
Five-year follow-up of a phase II study of DA-EPOCH-R with high-dose MTX in CD5-positive DLBCL.
Miyazaki K, Sakai R, Iwaki N, Yamamoto G, Murayama K, Nishikori M, Sunami K, Yoshida I, Yano H, Takahashi N, Okamoto A, Munemoto S, Sawazaki A, Suehiro Y, Fukuhara N, Wake A, Arai A, Masaki Y, Toyama K, Yokoyama A, Tsunemine H, Hasegawa Y, Matsumoto K, Yamada T, Nishimura Y, Tamaru S, Asano N, Miyawaki K, Izutsu K, Kinoshita T, Suzuki R, Ohshima K, Kato K, Katayama N, Yamaguchi M. Miyazaki K, et al. Among authors: sakai r. Cancer Sci. 2023 Jun;114(6):2689-2691. doi: 10.1111/cas.15784. Epub 2023 Mar 16. Cancer Sci. 2023. PMID: 36929591 Free PMC article. Clinical Trial. No abstract available.
Titanium Germylidenes.
Lee VY, Sakai R, Takanashi K, Gapurenko OA, Minyaev RM, Gornitzka H, Sekiguchi A. Lee VY, et al. Among authors: sakai r. Angew Chem Int Ed Engl. 2021 Feb 19;60(8):3951-3955. doi: 10.1002/anie.202015704. Epub 2021 Jan 26. Angew Chem Int Ed Engl. 2021. PMID: 33289313
Lidocaine ingestion.
Sakai RI, Lattin JE. Sakai RI, et al. Am J Dis Child. 1980 Mar;134(3):323. doi: 10.1001/archpedi.1980.02130150077023. Am J Dis Child. 1980. PMID: 7361745 No abstract available.
Tensor renormalization group for fermions.
Akiyama S, Meurice Y, Sakai R. Akiyama S, et al. Among authors: sakai r. J Phys Condens Matter. 2024 May 28;36(34). doi: 10.1088/1361-648X/ad4760. J Phys Condens Matter. 2024. PMID: 38701830 Review.
Social stress: from rodents to primates.
Tamashiro KL, Nguyen MM, Sakai RR. Tamashiro KL, et al. Among authors: sakai rr. Front Neuroendocrinol. 2005 Apr;26(1):27-40. doi: 10.1016/j.yfrne.2005.03.001. Front Neuroendocrinol. 2005. PMID: 15862183 Review.
1,060 results